Biological Sciences and Healthcare, part 4

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Nitrogen and nitrogen compound product > Product containing polypeptide (product) > Product containing protein (product) > Antibody product > Monoclonal antibody preparation > Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) > Product containing pembrolizumab (medicinal product) > Product containing pembrolizumab in parenteral dosage form (medicinal product form) > Product containing only pembrolizumab in parenteral dose form (medicinal product form) > Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Immunomodulator > Product containing programmed cell death protein 1 inhibitor (product) > Product containing pembrolizumab (medicinal product) > Product containing pembrolizumab in parenteral dosage form (medicinal product form) > Product containing only pembrolizumab in parenteral dose form (medicinal product form) > Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Nitrogen and nitrogen compound product > Product containing polypeptide (product) > Product containing protein (product) > Antibody product > Monoclonal antibody preparation > Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) > Product containing pembrolizumab (medicinal product) > Product containing only pembrolizumab (medicinal product) > Product containing only pembrolizumab in parenteral dose form (medicinal product form) > Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Immunomodulator > Product containing programmed cell death protein 1 inhibitor (product) > Product containing pembrolizumab (medicinal product) > Product containing only pembrolizumab (medicinal product) > Product containing only pembrolizumab in parenteral dose form (medicinal product form) > Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)